Retinoids as teratogens

Annual Review of Nutrition

Volumn 15, Issue , 1995, Pages 111-132

  Soprano, Dianne Robert ^a,b   Soprano, Kenneth J ^b,c  

^a Department of Biochemistry ^*  (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

dysmorphogenesis; RAR; retinoic acid; retinol; teratology

Indexed keywords

RETINOIC ACID RECEPTOR; RETINOID;

FETUS MALFORMATION; HOMEOBOX; HUMAN; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; RETINOL DEFICIENCY; RETINOL INTOXICATION; REVIEW; STRUCTURE ACTIVITY RELATION; TERATOGENICITY; VITAMIN METABOLISM;

ANIMALIA;

EID: 0029155026     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nu.15.070195.000551     Document Type: Review

References (120)

1. Adams J, Lammer EJ. 1991. Relationship between dysmorphogenesis and neuro-psychological function in children exposed to isotretinoin "in utero." In Functional Neuroteratology of Short-Term Exposure to Drugs, ed. T Fujii, GJ Boer, pp. 159-70. Tokyo: Teikyo Univ. Press
2. Adams J. 1990. High incidence of intellectual deficits in 5-year-old children exposed to isotretinoin in utero. Teratology 41:614
3. Agnish ND, Kochhar DM. 1993. Developmental toxicology of retinoids. See Ref. 60a, pp. 47-76.
4. Armstrong RB, Ashenfelter KO, Eckhoff C, Levin AA, Shapiro SS. 1994. General and reproductive toxicology of retinoids. See Ref. 100a, pp. 545-72.
5. Bechter R, Terlouw GDC, Tsuchiya M, Tsuchiya T, Kistler A. 1992. Teratogenicity of arotinoids (retinoids) in the rat whole embryo culture. Arch. Toxicol. 66:193-97
6. Benke PJ. 1984. The isotretinoin syndrome. J. Am. Med. Assoc. 251:2367-69
7. Boehm MF, Zhang L, Badea BA, White SK, Mais DE, et al. 1994. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J. Med. Chem. 37:2930-41
8. Bonicinelli E, Simeone A, Acampora D, Mavilio F. 1991. HOX gene activation by retinoic acid. Trends Genet. 7: 329-34
9. Brazell RK, Vane FM, Ehmann CW, Colburn WA. 1983. Pharmacokinetics of isotretinoin during repetitive dosing to patients. Eur. J. Clin. Pharmacol. 24:695-702
10. Camera G, Pregliasco P. 1992. Ear malformation in baby born to mother using tretinoin cream. Lancet 339:687
11. Cohlan SQ. 1953. Excessive intake of vitamin A as a cause of congenital anomalies in rat. Science 117:535-36
12. Cohlan SQ. 1954. Congenital anomalies in the rat produced by excessive intake of vitamin A during pregnancy. Pediatrics 13:556-57
13. Conlon RA, Rossant J. 1992. Exogenous retinoic acid rapidly induces anterior ectopic expression of murine Hoc-2 in vivo. Development 116:357-68
14. Creech Kraft J, Eckhoff C, Kochhar DM, Klug S, Bochert G, et al. 1991. Isotretinoin (13-cis-retinoic acid), metabolism, cis-trans isomerization and transfer to the embryo: consequences for teratogenicity. Teratog. Carcinog. Mutagen. 11:21-30
15. Creech Kraft J, Juchau MR. 1993. 9-cis-retinoic acid: a direct acting dysmorphogen. Biochem. Pharmacol. 46: 709-16
16. Creech Kraft J, Kochhar DM, Scott WJ, Nau H. 1987. Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentration during organogenesis: comparison to the all-trans isomer. Toxicol. Appl. Pharmacol. 87:474-82
17. Creech Kraft J, Lofberg B, Chahoud I, Bochert G, Nau H. 1989. Teratogenicity and placental transfer of all-trans, 13-cis, 4-oxo-all-trans and 4-oxo-13-cis retinoic acid after administration of low oral dose during organogenesis in mice. Toxicol. Appl. Pharmacol. 100:162-76
18. Creech Kraft J, Slikker W, Bailey JR, Roberts LG, Fischer B, et al. 1991. Plasma pharmacokinetics and metabolism of 13-cis and all-trans-retinoic acid in the cynomolgus monkey and the identification of 13-cis and all-trans-retinoyl-β-glucuronides. Drug Metab. Dispos. 19:316-24
19. Crettaz M, Baron A, Siegenthaler G, Hunziker W. 1990. Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta. Biochem. J. 272:391-97
20. Cruz DL. 1984. Multiple congenital malformations associated with maternal isotretinoin therapy. Pediatrics 74:428-30
21. Deschamps J, Meijlink F. 1992. Mammalian homeobox genes in normal development and neoplasia. Crit. Rev. Oncogen. 3:117-73
22. Dolle P, Fraulob V, Kastner P, Chambon P. 1994. Developmental expression of murine retinoid X receptor (RXR) genes. Mech. Dev. 45:91-104
23. Dolle P, Ruberte E, Kastner P, Petkovich M, Stoner CM, et al. 1989 Differential expression of gene encoding α, β, and γ retinoic acid receptors and CRABP in the developing limbs of the mouse. Nature 342:702-5
24. Dolle P, Ruberte E, Leroy P, Morriss-Kay G, Chambon P. 1990. Retinoic acid receptors and cellular retinoid binding proteins. I. A systematic study of their differential pattern of transcription during mouse organogenesis. Development 110:1133-51
25. Echelard Y, Epstein DJ, St-Jacques B, Shen L, Mohler J, et al. 1993. Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity Cell 75:1417-30
26. Eckhardt K, Schmitt G. 1994. A retinoic acid receptor alpha antagonist counter acts retinoid teratogenicity in vitro and reduced incidence and/or severity of malformations in vivo. Toxicol. Lett. 70:299-308
27. Eckhoff C, Bailey JR, Slikker W, Nau H. 1991. Placental transfer of retinoids following high-dose vitamin A during early pregnancy in the monkey. Teratology 43:444 (Abstr.)
28. Eckhoff C, Lofberg B, Chahoud I, Bochert G, Nau H. 1989. Transplacental pharmacokinetics and teratogenicity of a single dose of retinol (vitamin A) during organogenesis in the mouse Toxicol. Lett. 48:171-84
29. Faiella A, Zappavigna V, Mavilio F, Boncinelli E. 1994. Inhibition of retinoic acid-induced activation of 3′ human HOXB genes by antisense oligonu- cleotides affects sequential activation of genes located upstream in the four HOX clusters, Proc. Natl, Acad. Sci. USA 91:5335-39
30. Fantel AG, Shepard TH, Newell-Morris LL, Moffett BC. 1977. Teratogenic effects of retinoic acid in pigtail monkeys (Macaca nemestrina). I. General features. Teratology 15:65-72
31. Fernhoff PM, Lammer EJ. 1984. Craniofacial features of isotretinoin embryopathy. J. Pediatr. 105:595-97
32. Geelen JAG. 1978. Hypervitaminosis A induced teratogenesis. CRC Crit Rev. Toxicol. 6:351-75
33. Giroud A, Martinet, M. 1959. Entension à plusier espèces de mammifères des malformations embryonnaires par hypervitamose A. C. R. Soc. Biol. 153: 201-2
34. Gorry P, Lufkin T, Dierich A, Rochette-Egly C, Decimo D, et al. 1994. The cellular retinoic acid binding protein I is dispensable. Proc. Natl, Acad, Sci USA 91:9032-36
35. Gudas LJ, Sporn MB, Roberts AB 1994. Cellular biology and biochemistry of retinoids. See Ref. 100a, pp. 443-520
36. Gunning DB, Barua AB, Olson JA. 1993. Comparative teratogenicity and metabolism of all-trans retinoic acid, all-trans retinoyl-β-glucose, and all-trans retinoyl-β-glucuronide in pregnant Sprague-Dawley rats. Teratology 47: 29-36
37. Happle R, Traupe T, Bounameaux T, Fisch T. 1984. Teratogene Werkung von Etretinat beim Menschen. Dtsch. Med. Wochenschr. 109:1476-80
38. Harnish DC, Barua AB, Soprano KJ, Soprano DR. 1990. Induction of β-retinoic acid receptor mRNA by teratogenic doses of retinoids in murine fetuses. Differentiation 45:103-8
39. Harnish DC, Jiang H, Soprano KJ, Kochhar DM, Soprano DR. 1992. Retinoic acid receptor β2 mRNA is elevated by retinoic acid in vivo in susceptible regions of mid-gestation mouse embryos. Dev. Dyn. 194:239-46
40. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, et al. 1992. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397-406
41. Hill DL, Grubbs CJ. 1992. Retinoids and cancer prevention. Anna. Rev. Nutr. 12:161-81
42. Hofmann C, Eichele G. 1994. Retinoids in development. See Ref. 100a, pp. 387-441
43. Hong WK, Itri LM. 1994. Retinoids and human cancer. See Ref. 100a, pp. 597-630
44. Howard WB, Sharma RP, Willhite CC, Dawson MI. 1990. Binding affinities of retinoids to fetal cellular retinoic acid-binding protein (CRABP) in relation to their teratogenic potential. Biochem. Pharmacol. 40:643-48
45. Howard WB, Willhite CC, Dawson MI, Sharma RP. 1988. Structure-activity relationships of retinoids in developmental toxicology. III. Contribution of the vitamin A betacyclgeranylidene ring. Toxicol. Appl. Pharmacol. 95:122-38
46. Izpisua-Belmonte J, Dolle P, Duboule D. 1991. Hox genes and the molecular basis of vertebrate limb pattern formation. Semin. Dev. Biol. 2:385-91
47. Jiang H, Gyda M, Harnish DC, Chandraratna RA, Soprano KJ, et al. 1994. Teratogenesis by retinoic acid analogs positively correlates with elevation of retinoic acid receptor-β2 mRNA levels in treated embryos. Teratology 50:38-43.
48. Deleted in proof
49. Kalin JR, Starling ME, Hill DL. 1981. Disposition of all-trans-retinoic acid in mice following oral doses. Drug Metab. Dispos. 9:196-201
50. Kalin JR, Wells MJ, Hill DL. 1982. Disposition of 13-cis-retinoic acid and N-(2-hydroxyethyl)retinamide in mice after oral doses. Drug. Metab. Dispos. 10:391-98
51. Kalter H. 1960. The teratogenic effects of hypervitaminosis A upon the face and mouth of inbred mice. Ann. N. Y. Acad. Sci. 85:42-55
52. Kalter H, Warkany J. 1961. Experimental production of congenital malformations in strains of inbred mice by maternal treatment with hypervitaminosis. Am. J. Pathol. 38:1-15
53. Kistler A. 1981. Teratogenesis of retinoic acid in rats: susceptible stages and suppression of retinoic acid-induced limb malformations by cycloheximide. Teratology 23:25-31
54. Kistler A, Galli B, Howard WB. 1990. Comparative teratogenicity of three retinoids: the arotinoids Ro 14-7410, Ro 13-6298 and Ro 15-1570. Arch. Toxicol. 64:43-48
55. Kochhar DM. 1967. Teratogenic activity of retinoic acid. Acta Pathol. Microbiol. Scand. 70:393-404
56. Kochhar DM. 1973. Limb development in mouse embryos. I. Analysis of teratogenic effects of retinoic acid. Teratology 7:289-98
57. Kochhar DM, Johnson EM. 1965. Morphological and autoradiographic studies of cleft palate induced in rat embryos by maternal hypervitaminosis A. J. Embryol. Exp. Morphol. 14:223-29
58. Kochhar DM, Penner JD. 1987. Developmental effects of isotretinoin and 4-oxo-isotretinoin: the role of metabolism in teratogenicity. Teratology 36:67-75
59. Kochhar DM, Penner JD. 1992. Analysis of high dysmorphogenic activity of Ro 13-6307, a tetramethylated tetralin analog of retinoic acid. Teratology 45: 637-45
60. Kochhar DM, Penner JD, Satre MA. 1988. Derivation of retinoic acid and metabolites from a teratogenic dose of retinol (vitamin A) in mice. Toxicol. Appl. Pharmacol. 96:429-41
61. 60a. Koren G, ed. 1993. Retinoids: The Risk-Benefit Ratio. New York: Dekker
62. Lammer EJ. 1988. Embryopathy in infant conceived one year after termination of maternal etretinate. Lancet 2: 1089-81
63. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, et al. 1985. Retinoic acid embryopathy. New Engl. J. Med. 313:837-41
64. Langsten AW, Gudas LJ. 1992. Identification of a retinoic acid responsive enhancer 3′ of the murine homeobox gene Hox 1.6. Mech. Dev. 38:217-28
65. LaRosa GJ, Gudas LJ. 1988. An early effect of retinoic acid: cloning of an mRNA (Era-1) exhibiting rapid and protein synthesis-independent induction during teratocarcinoma stem-cell differentiation. Proc. Natl. Acad. Sci. USA 85:329-33
66. Lehmann JM, Dawson Ml, Hobbs PD, Husmann M, Pfahl M. 1991. Identification of retinoids with nuclear receptor subtype-selective activities. Cancer Res. 51:4804-9
67. Lehmann JM, Jong L, Fanjul A, Cameron JF, Lu XP, et al. 1992. Retinoids selective for retinoid X receptor response pathways. Science 258:1944-46
68. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski C, Huselton G, et al. 1992. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355:359-61
69. Li E, Suvov HM, Lee KF, Evans RM, Jaenisch R. 1993. Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene. Proc. Natl. Acad. Sci. USA 90:1590-94
70. Lofberg B, Chahoud I, Bochert G, Nau H. 1990. Teratogenicity of the 13-cis and all-trans-isomers of the aromatic retinoid etretin: correlation to transplacental pharmacokinetics in mice during organogenesis after a single oral dose. Teratology 41:707-16
71. Lohnes D, Kastner P, Dierich A, Mark M. LeMeur M, et al. 1993. Function of retinoic acid receptor gamma in the mouse. Cell 73:643-58
72. Lombardo A, Costa E, Chao WR, Toll L, Hobbs PD. et al. 1994. Recombinant human retinoic acid receptor beta. Binding of synthetic retinoids and transcriptional activation. J. Biol. Chem. 269: 7297-303
73. Lott IT. 1983. Fetal hydrocephalus and ear anomalies associated with maternal use of isotretinoin. J. Pediatr. 105:597-600
74. Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, et al. 1993. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc. Natl. Acad. Sci. USA 90:7225-29
75. Mangelsdorf DJ, Umesono K, Evans RM. 1993. The retinoid receptors. See Ref. 100a, pp. 319-50
76. Marshall H, Nonchev S, Sham MH, Muchamore I, Lumsden A, Krumlauf R. 1992. Retinoic acid alters hindbrain Hox code and induces transformation of rhombomeres 2/3 into a 4/5 identity Nature 360:737-41
77. Marshall H, Studer M, Popperyl H, Aparicio S, Kuroiwa A, et al. 1994. A conserved retinoic acid response element required for the early expression of the homeobox gene Hoxb-1. Nature 370:567-71
78. Massarella J, Vane F, Gugge C, Rodriquez L, Cunningham WJ, et al. 1985 Etretinate kinetics during chronic dosing in severe psoriasis. Clin. Pharmacol. Ther. 37:439-46
79. Mavilio F. 1993. Regulation of vertebrate homeobox-containing genes by morphogens. Eur. J. Biochem. 212:273-88
80. Morgan BA. Izpisua-Belmonte JC, Duboule D, Tabin CJ. 1992. Targeted misexpression of Hox 4.6 in the avian limb bud causes apparent homeotic transformations. Nature 358:236-39
81. Moms GM, Steele CE. 1977. Comparison of the effects of retinol and retinoic acid on postimplantation rat embryos in vitro. Teratology 15:109-20
82. Muindi JRF, Frankel SR, Huselton C, Degrazia F, Garland WA, et al. 1992 Clinical pharmacolgy of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 52:2138-42
83. Nau H. 1990. Correlation of transplacental and maternal pharmacokinetics of retinoids during organogenesis with teratogenicity. Methods Enzymol. 190: 437-48
84. Nau H. 1993. Teratogenesis, transplacental pharmacokinetics, and metabolism of some retinoids in the mouse, monkey and humans. In Retinoids: Progress in Research and Clinical Application, ed. M Livrea, L Packer, pp 599-616. New York: Dekker
85. Nau H. 1994. Retinoid teratogenesis: toxicokinetics and structure-specificity. Arch. Toxicol. 16(Suppl.):118-27
86. Peck GL, DiGiovanna JJ. 1994. Synthetic retinoids in dermatology. See Ref. 100a, pp. 631-58
87. Petkovich M. 1992. Regulation of gene expression by vitamin A: the role of nuclear retinoic acid receptors. Annu Rev. Nutr. 12:443-71
88. Popperyl H, Featherstone MS. 1993 identification of a retinoic acid response element upstream of the murine Hox-4.2 gene. Mol. Cell. Biol. 13:257-65
89. Riddle RD, Johnson RL, Laufer E, Tabin C. 1993. Sonic hedgehog medi-ates the polarizing activity of ZPA. Cell 75:1401-16
90. Roche Laboratories. 1985. Presentation to FDA advisory committee and public hearing on etretinate safety, June 1985
91. Rollman O, Vahlquist A. 1983. Retinoid concentrations in skin, serum and adipose tissue of patients treated with estrinate. Br. J. Dermatol. 109:439-47
92. Rosa FW. 1983. Teratogenicity of isotretinoin. Lancet 2:513
93. Rosa FW. 1992. Retinoid embryopathy in humans. See Ref. 60a
94. Rosa FW, Wilk AL, Kelsey FO. 1986. Teratogen update: vitamin A congeners. Teratology 33:355-64
95. Ruberte E, Dolle P, Chambon P, Morriss-Kay G. 1991. Retinoic acid receptors and cellular retinoic acid binding proteins. 11. Their differential pattern of transcription during early morphogenesis in mouse embryos. Development 111:45-60
96. Ruberte E, Dolle P, Krust A, Zelent G, Morriss-Kay G, et al. 1990. Spatial and temporal distribution of retinoic acid receptor gamma transcripts during early morphogenesis in mouse embryos. Development 108:213-22
97. Ruberte E, Friederich V, Chambon P, Morriss-Kay G. 1993. Retinoic acid receptors and cellular retinoid binding proteins. III. Their differential transcript distribution during mouse nervous system development. Development 118: 267-82
98. Satre M, Penner JD, Kochhar DM. 1989. Pharmacokinetic assessment of teratologically effective concentrations of an endogenous retinoic acid metabolite. Teratology 39:341-48
99. Shenefelt RE. 1972. Morphogenesis of malformations in hamsters caused by retinoic acid: relationship to dose and stage of treatment. Teratology 5:103-18
100. Simeone A, Acampora D, Arcioni L, Andrews PW, Boncinelli W, Mavilio F. 1990. Sequential activation of HOX2 homeobox genes by retinoic acid in human embryonal carcinoma cells. Nature 346:763-66
101. Soprano DR, Gyda M, Jiang H, Harnish DC, Ugen K, et al. 1994. A sustained elevation in retinoic acid receptor-β2 mRNA and protein occurs during retinoic acid-induced fetal dysmorphogenesis. Mech. Dev. 45:243-53
102. 100a. Sporn MB, Roberts AB, Goodman DS, eds. 1993. The Retinoids: Biology, Chemistry and Medicine. New York: Raven. 2nd ed.
103. Steele CE, Marlow R, Turton J, Hicks RM. 1987. In vitro teratogenicity of retinoids. Br. J. Exp. Pathol. 68:215-23
104. Stunnenberg HG. 1993. Mechanism of transactivation by retinoic acid receptors. BioEssays 15:309-15
105. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, et al. 1994. RXR mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 8:1007-18
106. Tabin CJ. 1991. Retinoids, homeoboxes and growth factors - toward molecular models for limb development. Cell 66:199-217
107. 220 of retinoic acid receptor-β are important for the binding of retinoic acid. J. Biol. Chem. 269:19516-22
108. Deleted in proof
109. Thompson JN, Howell J, Pitt GA. 1964. Vitamin A and reproduction in the rat. Proc. R. Soc. London Ser. B 159:510-23
110. Wald G. 1968. Molecular basis of visual excitation. Science 162:230
111. Willhite CC. 1986. Structure-activity relationships of retinoids in developmental toxicology. II. Influence of the polyene chain of the vitamin A molecule. Toxicol. Appl. Pharmacol. 83:563-75
112. Willhite CC. 1990. Molecular correlates in retinoid pharmacology and toxicology. In Chemistry and Biology of Synthetic Retinoids. ed. MI Dawson, WH Okamura, pp. 539-73. Boca Raton, FL: CRC
113. Willhite CC, Dawson MI. 1990. Structure-activity relationships of retinoids in developmental toxicology. IV. Planar cisoid conformational restriction. Toxicol. Appl. Pharmacol. 103:324-14
114. Willhite CC, Dawson MI, Williams KJ. 1984. Structure-activity relationships of retinoids in developmental toxicology. I. Studies on the nature of the polar terminus of the vitamin A molecule. Toxicol. Appl. Pharmacol. 74:397-110
115. Willhite CC, Sharma RP, Allen PV, Berry DL. 1990. Percutaneous retinoid absorption and embryotoxicity. J. Invest. Dermatol. 95:523-29
116. Willhite CC, Shealy YF. 1984. Amelioration of embryotoxicity by structural modification of the terminal group of cancer chemopreventive retinoids. J. Natl. Cancer lust. 72:689-95
117. Willhite CC, Wier PJ, Berry DL. 1989. Dose reponse and structure-activity considerations in retinoid-induced dysmorphogenesis. Crit. Rev. Toxicol. 20: 113-35
118. Wolback SB. Howe PR. 1933. Epithelial repair in recovery from vitamin A deficiency. J. Exp. Med. 57:511-27
119. Wolback SB, Howe PR. 1925. Tissue changes following deprivation of fat-soluble A vitamin. J. Exp. Med. 42:753-71
120. Zbinden G. 1975. Investigations on the toxicity of tretinoin administered systemically to animals. Acta Dermatol. Venereol 118(Suppl.):36-40